NCT04171726View on ClinicalTrials.gov

Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation

PHASE3UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

June 1, 2023

Study Completion Date

September 1, 2023

Conditions
Aortic Valve Stenosis
Interventions
DRUG

Edoxaban

A non-vitamin K antagonist (VKA) oral anticoagulant that selectively inhibits factor Xa.

Trial Locations (1)

3015GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Erasmus Medical Center

OTHER